The Potential of Tetrandrine As a Protective Agent for Ischemic Stroke

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2011 Sep 20

PMID 21926947

Citations 23

Authors

Yun Chen

Ya-Hui Tsai

Sheng-Hong Tseng

Affiliations

Soon will be listed here.

Abstract

Stroke is one of the leading causes of mortality, with a high incidence of severe morbidity in survivors. The treatment to minimize tissue injury after stroke is still unsatisfactory and it is mandatory to develop effective treatment strategies for stroke. The pathophysiology of ischemic stroke is complex and involves many processes including energy failure, loss of ion homeostasis, increased intracellular calcium level, platelet aggregation, production of reactive oxygen species, disruption of blood brain barrier, and inflammation and leukocyte infiltration, etc. Tetrandrine, a bisbenzylisoquinoline alkaloid, has many pharmacologic effects including anti-inflammatory and cytoprotective effects. In addition, tetrandrine has been found to protect the liver, heart, small bowel and brain from ischemia/reperfusion injury. It is a calcium channel blocker, and can inhibit lipid peroxidation, reduce generation of reactive oxygen species, suppress the production of cytokines and inflammatory mediators, inhibit neutrophil recruitment and platelet aggregation, which are all devastating factors during ischemia/reperfusion injury of the brain. Because tetrandrine can counteract these important pathophysiological processes of ischemic stroke, it has the potential to be a protective agent for ischemic stroke.

Citing Articles

Insights on exploring the therapeutic potential and structural modification of Tetrandrine.

Gong L, Liu H, Xu B, Yu T, Wang Y, Niu S Future Med Chem. 2024; 16(24):2687-2700.

PMID: 39606807 PMC: 11731063. DOI: 10.1080/17568919.2024.2432297.

MicroRNA‑27a‑3p regulates the proliferation and chemotaxis of pulmonary macrophages in non‑small cell lung carcinoma tissues through CXCL2.

Zhai C, Liu B, Kan F, Zhai S, Zhang R Oncol Lett. 2023; 26(5):492.

PMID: 37854860 PMC: 10579986. DOI: 10.3892/ol.2023.14079.

Study on the mechanism of oral administration of tetrandrine during neoadjuvant chemotherapy for colon cancer.

Li D, Li J, Yu F, Wang B, Liu B Oncol Lett. 2023; 25(6):225.

PMID: 37153045 PMC: 10160847. DOI: 10.3892/ol.2023.13811.

Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress.

Samsuzzaman M, Jang B Biomolecules. 2022; 12(6).

PMID: 35740967 PMC: 9221093. DOI: 10.3390/biom12060843.

Tetrandrine Ameliorates Traumatic Brain Injury by Regulating Autophagy to Reduce Ferroptosis.

Liu H, He S, Wang J, Li C, Liao Y, Zou Q Neurochem Res. 2022; 47(6):1574-1587.

PMID: 35266084 DOI: 10.1007/s11064-022-03553-9.

References

Herman E, Chadwick D . Cardiovascular effects of d-tetrandrine. Pharmacology. 1974; 12(2):97-109. DOI: 10.1159/000136527. View

Ye J, Ding M, Zhang X, Rojanasakul Y, Shi X . On the role of hydroxyl radical and the effect of tetrandrine on nuclear factor--kappaB activation by phorbol 12-myristate 13-acetate. Ann Clin Lab Sci. 2000; 30(1):65-71. View

Teh B, Ioannoni B, Seow W, McCormack J, Thong Y . Suppression by tetrandrine of human platelet aggregation induced by platelet-activating factor and other stimulants. Int Arch Allergy Appl Immunol. 1989; 88(3):267-72. DOI: 10.1159/000234805. View

Ho L, Chang D, Chang M, Kuo S, Lai J . Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J Rheumatol. 1999; 26(1):14-24. View

Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T . Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 1994; 25(7):1469-75. DOI: 10.1161/01.str.25.7.1469. View

Im J, Kim D, Paik S, Han P . Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation. Free Radic Biol Med. 2006; 41(6):960-72. DOI: 10.1016/j.freeradbiomed.2006.06.001. View

Wong C, Thong Y, Seow W . Comparative effects of tetrandrine and berbamine on guineapig airway microvascular leakage induced by platelet-activating factor and other allergic mediators. Int J Immunopharmacol. 1993; 15(2):185-93. DOI: 10.1016/0192-0561(93)90094-f. View

Zhou Y, Fang X, Cui Z . UVA-induced calcium oscillations in rat mast cells. Cell Calcium. 2008; 45(1):18-28. DOI: 10.1016/j.ceca.2008.05.003. View

Chang D, Chang W, Kuo S, Chang M . The effects of traditional antirheumatic herbal medicines on immune response cells. J Rheumatol. 1997; 24(3):436-41. View

10.

Goussev A, Zhang Z, Anderson D, Chopp M . P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat. J Neurol Sci. 1999; 161(1):16-22. DOI: 10.1016/s0022-510x(98)00262-7. View

11.

Gralla E, Coleman G, Jonas A . Toxicology studies with d-tetrandrine (NSC-77037), a plant alkaloid with vascular and lymphotoxic effects in dogs and monkeys. Cancer Chemother Rep 3. 1974; 5(1):79-85. View

12.

Jin R, Yang G, Li G . Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010; 87(5):779-89. PMC: 2858674. DOI: 10.1189/jlb.1109766. View

13.

Arumugam T, Granger D, Mattson M . Stroke and T-cells. Neuromolecular Med. 2005; 7(3):229-42. DOI: 10.1385/NMM:7:3:229. View

14.

Wang H, Kilfeather S, Martin G, Page C . Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells. Pulm Pharmacol Ther. 2000; 13(2):53-60. DOI: 10.1006/pupt.2000.0230. View

15.

Mehta S, Manhas N, Raghubir R . Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev. 2007; 54(1):34-66. DOI: 10.1016/j.brainresrev.2006.11.003. View

16.

Chen F, Sun S, Kuhn D, Lu Y, Gaydos L, Shi X . Tetrandrine inhibits signal-induced NF-kappa B activation in rat alveolar macrophages. Biochem Biophys Res Commun. 1997; 231(1):99-102. DOI: 10.1006/bbrc.1997.6057. View

17.

Shen Y, Chou C, Chiou W, Chen C . Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol Pharmacol. 2001; 60(5):1083-90. View

18.

Allen C, Bayraktutan U . Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009; 4(6):461-70. DOI: 10.1111/j.1747-4949.2009.00387.x. View

19.

Huang M, Wu S, Shen A . Inhibition of Ca2+-activated and voltage-dependent K+ currents by 2-mercaptophenyl-1,4-naphthoquinone in pituitary GH3 cells: contribution to its antiproliferative effect. Life Sci. 2002; 70(10):1185-203. DOI: 10.1016/s0024-3205(01)01489-8. View

20.

Fernandes M, Custodio J, Santos M, Moreno A, Vicente J . Tetrandrine concentrations not affecting oxidative phosphorylation protect rat liver mitochondria from oxidative stress. Mitochondrion. 2006; 6(4):176-85. DOI: 10.1016/j.mito.2006.06.002. View